Company news: Bod; Neurotech International; Emyria; Creso Pharma by Martin Lane August 23, 2022April 29, 2024 Bod Australia Bod has been awarded US Hemp Authority Certification for its CBD extract and CBD […]
Neurotech International announces breakthrough results from autism study by Martin Lane July 8, 2022April 29, 2024
Neurotech results could lead to treatment alternatives for range of neuroinflammatory disorders by Martin Lane June 10, 2022April 29, 2024
Neurotech secures cultivation partnership with CannaPacific by Martin Lane March 10, 2021April 26, 2024
Neurotech extends licence to include all neurological disorders by Martin Lane March 3, 2021April 26, 2024
Neurotech International completes in-vitro studies of its proprietary cannabis leads, clinical trials to follow by Martin Lane December 22, 2020April 26, 2024
Neurotech International’s new chairman to focus on cannabis treatments for cognitive disorders by Emma Castle November 2, 2020April 26, 2024
